Beacon Financial Group Has Lifted Holding in Walt Disney Co (DIS) by $1.78 Million; As Merck & Co (MRK) Share Value Rose, Edgemoor Investment Advisors Has Cut by $422,880 Its Holding

Merck & Co., Inc. (NYSE:MRK) Logo

Beacon Financial Group increased its stake in Walt Disney Co (DIS) by 297.29% based on its latest 2018Q2 regulatory filing with the SEC. Beacon Financial Group bought 17,091 shares as the company’s stock rose 2.96% with the market. The institutional investor held 22,840 shares of the television services company at the end of 2018Q2, valued at $2.39M, up from 5,749 at the end of the previous reported quarter. Beacon Financial Group who had been investing in Walt Disney Co for a number of months, seems to be bullish on the $166.70 billion market cap company. The stock decreased 1.30% or $1.47 during the last trading session, reaching $111.98. About 8.31M shares traded or 2.53% up from the average. The Walt Disney Company (NYSE:DIS) has risen 11.82% since December 8, 2017 and is uptrending. It has underperformed by 3.80% the S&P500. Some Historical DIS News: 10/05/2018 – Comcast to match Disney break fee in race for Fox; 08/03/2018 – DISNEY `MARY POPPINS’ REBOOT STARS MERYL STREEP, DICK VAN DYKE; 18/05/2018 – Mashable: The 15 best and most bizarre Disney Channel Original Movies; 08/03/2018 – Jon Favreau Set To Write, Produce Live-action ‘Star Wars’ TV Series For Disney Streaming Service — MarketWatch; 08/03/2018 – Shareholders Elect 10 Directors at The Walt Disney Company Annual Meeting; 08/05/2018 – Disney could choose to split Fox’s assets with Comcast in lieu of a bidding war; 23/05/2018 – The Today Show: #BREAKING: Etihad Stadium has been giving a shock new name, after a massive deal with Disney. #9Toda; 07/05/2018 – The Edge Markets: M&A: Comcast prepares all-cash bid to gate-crash Disney-Fox deal – sources – The Edge Markets; 11/03/2018 – Comcast disrupts Murdoch’s entertainment deal with Disney; 29/05/2018 – ABC cancels TV’s ‘Roseanne’ hours after star’s racist ‘ape’ tweet

Edgemoor Investment Advisors Inc decreased its stake in Merck & Co Inc (MRK) by 6.26% based on its latest 2018Q2 regulatory filing with the SEC. Edgemoor Investment Advisors Inc sold 7,048 shares as the company’s stock rose 11.62% with the market. The institutional investor held 105,542 shares of the health care company at the end of 2018Q2, valued at $6.41 million, down from 112,590 at the end of the previous reported quarter. Edgemoor Investment Advisors Inc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $199.50B market cap company. The stock decreased 2.11% or $1.65 during the last trading session, reaching $76.72. About 12.62 million shares traded or 11.63% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 6.72% since December 8, 2017 and is uptrending. It has underperformed by 8.90% the S&P500. Some Historical MRK News: 03/05/2018 – BMY: EMA VALIDATED TYPE II VARIATION APPLICATION FOR OPDIVO; 01/05/2018 – MERCK & CO SEES FY ADJ EPS $4.16 TO $4.28, SAW $4.08 TO $4.23; 06/03/2018 – Faster, more convenient Opdivo dosing schedules gives Bristol-Myers added edge in battle of the PD-1 blockbusters with Merck $BMY $MRK; 06/03/2018 – Bristol-Myers Squibb’s Opdivo(R) (nivolumab) Now The First And Only FDA-Approved PD-1 Inhibitor To Offer Every Four-Week Dosing; 09/04/2018 – KEYTRUDA® (pembrolizumab) Monotherapy Met Primary Endpoint in Phase 3 KEYNOTE-042 Study, Significantly Improving OS as First; 15/05/2018 – Merck KGaA 1Q Ebitda Pre-Exceptionals at EUR1.01B; 03/05/2018 – BSE Mumbai Bourse: Results from Merck for Jan 01 to Mar 31; 17/04/2018 – MERCK TO STUDY PCV-15 V114 FOR PNEUMOCOCCAL DISEASE VACCINE; 08/05/2018 – OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of lmmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer; 13/04/2018 – BRISTOL-MYERS SQUIBB- IN TRIAL, TWO SECONDARY ENDPOINTS OF ORR, MEDIAN DURATION OF RESPONSE DEMONSTRATED DURABILITY WITH OPDIVO VS DOCETAXEL

Investors sentiment is 1 in Q2 2018. Its the same as in 2018Q1. It is the same, as 48 investors sold MRK shares while 608 reduced holdings. only 126 funds opened positions while 530 raised stakes. 1.88 billion shares or 1.46% less from 1.91 billion shares in 2018Q1 were reported. Rhumbline Advisers holds 0.54% or 4.42M shares. Boston And Management holds 43,189 shares or 1.29% of its portfolio. The California-based Investors has invested 1.36% in Merck & Co., Inc. (NYSE:MRK). Tiaa Cref Invest Management Llc has 0.45% invested in Merck & Co., Inc. (NYSE:MRK). Moreover, C World Wide Gp Hldg A S has 0.28% invested in Merck & Co., Inc. (NYSE:MRK). Private Tru Na reported 59,745 shares. The Alabama-based Rfg Advisory Group Ltd Liability Company has invested 0.1% in Merck & Co., Inc. (NYSE:MRK). Towercrest Capital Mgmt reported 7,241 shares or 0.14% of all its holdings. Stearns Fincl Grp reported 5,727 shares. Sanders Ltd Liability Corporation invested in 3.58M shares. Stone Ridge Asset Management Ltd Liability Corporation owns 13,314 shares. Foster Dykema Cabot And Ma invested in 0.07% or 6,390 shares. Northwestern Mutual Wealth Mgmt Com has 294,104 shares. Buckingham Cap Mngmt invested in 61,433 shares or 0.76% of the stock. Oppenheimer Asset Inc accumulated 352,613 shares or 0.52% of the stock.

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on February, 1. They expect $1.04 EPS, up 6.12% or $0.06 from last year’s $0.98 per share. MRK’s profit will be $2.70 billion for 18.44 P/E if the $1.04 EPS becomes a reality. After $1.19 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -12.61% negative EPS growth.

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 99 analyst reports since August 13, 2015 according to SRatingsIntel. DZ Bank upgraded the stock to “Buy” rating in Tuesday, February 13 report. The rating was upgraded by Bank of America to “Buy” on Thursday, October 13. As per Tuesday, November 28, the company rating was maintained by Bank of America. The firm earned “Market Perform” rating on Tuesday, February 6 by Leerink Swann. Leerink Swann upgraded Merck & Co., Inc. (NYSE:MRK) rating on Monday, March 12. Leerink Swann has “Buy” rating and $66.0 target. The rating was maintained by BMO Capital Markets on Monday, October 22 with “Outperform”. The stock of Merck & Co., Inc. (NYSE:MRK) has “Hold” rating given on Wednesday, September 30 by Societe Generale. The firm earned “Sell” rating on Tuesday, July 4 by BMO Capital Markets. Credit Suisse maintained it with “Outperform” rating and $73 target in Friday, September 8 report. Cowen & Co maintained Merck & Co., Inc. (NYSE:MRK) on Friday, November 3 with “Hold” rating.

Edgemoor Investment Advisors Inc, which manages about $707.10 million and $748.00 million US Long portfolio, upped its stake in Blackrock Inc (NYSE:BLK) by 937 shares to 21,139 shares, valued at $10.55M in 2018Q2, according to the filing. It also increased its holding in Ishares Tr (AGG) by 21,184 shares in the quarter, for a total of 100,349 shares, and has risen its stake in Enbridge Inc (NYSE:ENB).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “A Short-Term Outlook For Merck – Seeking Alpha” on November 26, 2018, also Streetinsider.com with their article: “Ra Pharmaceuticals (RARX) Secures Development Milestone Payment Under Agreement with Merck (MRK) – StreetInsider.com” published on December 06, 2018, 247Wallst.com published: “Major Health Care Catalysts Coming by the End of 2018 – 24/7 Wall St.” on December 08, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Fool.com and their article: “3 Big Pharma Stocks Hitting 52-Week Highs — Are They Buys? – Motley Fool” published on December 04, 2018 as well as Seekingalpha.com‘s news article titled: “Merck starts rolling BLA for Ebola vaccine – Seeking Alpha” with publication date: November 13, 2018.

More notable recent The Walt Disney Company (NYSE:DIS) news were published by: Investorplace.com which released: “Disney Stock Still Has an ESPN Problem – Investorplace.com” on November 27, 2018, also Investorplace.com with their article: “Disney Earnings: DIS Stock Gains on Q4 Earnings, Revenue Beat – Investorplace.com” published on November 08, 2018, Bizjournals.com published: “Patent recap: A peek into the Disney tech filed in 2018 – Orlando Business Journal” on December 04, 2018. More interesting news about The Walt Disney Company (NYSE:DIS) were released by: Fool.com and their article: “Stock Market Power Rankings: Microsoft Parties Like Its 2002 – The Motley Fool” published on December 02, 2018 as well as Investorplace.com‘s news article titled: “Tuesday’s Vital Data: Disney, Nvidia and Square – Investorplace.com” with publication date: November 20, 2018.

Since July 2, 2018, it had 0 insider purchases, and 6 sales for $24.52 million activity. Parker Mary Jayne sold $3.44 million worth of stock or 29,192 shares. Shares for $15.05 million were sold by BRAVERMAN ALAN N. $5.73M worth of The Walt Disney Company (NYSE:DIS) was sold by IGER ROBERT A.

Among 40 analysts covering The Walt Disney Company (NYSE:DIS), 25 have Buy rating, 2 Sell and 13 Hold. Therefore 63% are positive. The Walt Disney Company had 166 analyst reports since July 24, 2015 according to SRatingsIntel. Morgan Stanley maintained the shares of DIS in report on Wednesday, January 31 with “Overweight” rating. Credit Suisse maintained the stock with “Buy” rating in Wednesday, August 9 report. FBR Capital maintained the shares of DIS in report on Thursday, May 25 with “Hold” rating. The firm has “Outperform” rating by Credit Suisse given on Tuesday, November 10. The company was maintained on Friday, August 28 by Cowen & Co. The firm has “Buy” rating by Topeka Capital Markets given on Thursday, November 19. The firm has “Hold” rating by Wells Fargo given on Tuesday, August 25. RBC Capital Markets upgraded The Walt Disney Company (NYSE:DIS) rating on Monday, October 9. RBC Capital Markets has “Top Pick” rating and $125 target. On Wednesday, August 9 the stock rating was maintained by Needham with “Hold”. BMO Capital Markets maintained The Walt Disney Company (NYSE:DIS) rating on Wednesday, August 8. BMO Capital Markets has “Market Perform” rating and $110 target.

Investors sentiment increased to 1.23 in 2018 Q2. Its up 0.19, from 1.04 in 2018Q1. It increased, as 51 investors sold DIS shares while 573 reduced holdings. 146 funds opened positions while 620 raised stakes. 976.63 million shares or 7.70% more from 906.82 million shares in 2018Q1 were reported. Mcdaniel Terry & holds 1,983 shares or 0.04% of its portfolio. Winfield Assocs holds 4,980 shares. Kempner Mgmt Incorporated owns 30,840 shares. Hartford Mngmt Inc holds 1.21% of its portfolio in The Walt Disney Company (NYSE:DIS) for 32,475 shares. Pensionfund Dsm Netherlands accumulated 48,200 shares or 0.89% of the stock. Northcoast Asset Management Limited Liability stated it has 0.04% of its portfolio in The Walt Disney Company (NYSE:DIS). Moreover, Scharf Invests has 2.73% invested in The Walt Disney Company (NYSE:DIS). Roosevelt Invest Grp holds 1.01% of its portfolio in The Walt Disney Company (NYSE:DIS) for 102,692 shares. Comerica Securities Incorporated has 0.25% invested in The Walt Disney Company (NYSE:DIS). Summit Wealth Advsr Ltd Limited Liability Company holds 0.07% of its portfolio in The Walt Disney Company (NYSE:DIS) for 2,223 shares. Spirit Of America Management Corp holds 0.18% of its portfolio in The Walt Disney Company (NYSE:DIS) for 14,000 shares. The Pennsylvania-based Private Wealth Advsr has invested 1.12% in The Walt Disney Company (NYSE:DIS). Ubs Oconnor Llc holds 50,142 shares. Trilogy Global Advsrs Lp holds 37,627 shares or 0.39% of its portfolio. Ajo Limited Partnership has invested 0.16% in The Walt Disney Company (NYSE:DIS).

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.